--- title: "Kyowa Kirin secures FDA approval for Crysvita dosing update" type: "News" locale: "en" url: "https://longbridge.com/en/news/286546805.md" description: "Kyowa Kirin has received FDA approval for an updated dosing regimen of Crysvita, a treatment for X-linked hypophosphatemia (XLH). The new guidelines allow healthcare providers to increase the dose and frequency for patients with low serum phosphorus levels. Crysvita, a monoclonal antibody, targets FGF23 to improve phosphorus retention and vitamin D levels. This update aims to provide a more personalized treatment approach for XLH patients, enhancing their care options." datetime: "2026-05-15T08:42:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286546805.md) - [en](https://longbridge.com/en/news/286546805.md) - [zh-HK](https://longbridge.com/zh-HK/news/286546805.md) --- # Kyowa Kirin secures FDA approval for Crysvita dosing update A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser. ### Related Stocks - [4151.JP](https://longbridge.com/en/quote/4151.JP.md) ## Related News & Research - [METLEN's Strategic Investment in Gallium Production Receives Ministerial Approval](https://longbridge.com/en/news/286578080.md) - [Kelun-Biotech Wins China IND Approval for Bispecific Cancer Antibody SKB118](https://longbridge.com/en/news/286173310.md) - [](https://longbridge.com/en/news/286780814.md) - [Leo Cancer Care Secures CE Mark for Marie®, Advancing Upright Radiotherapy in Europe](https://longbridge.com/en/news/287085225.md) - [Asia Orient says HK$760 million refinancing pending one bank approval](https://longbridge.com/en/news/287065990.md)